|Title:|| Uses for antibodies which bind to human somatomedin carrier protein subunits|
|Abstract:||This invention relates to polypeptides that are human somatomedin carrier protein subunits and to processes for producing them. The carrier protein subunits bind to human somatomedin-like polypeptides, also known as insulin-like growth factors. The process involves preparation from a human serum fraction, Cohn IV-1, by a molecule of various chromatographic steps. This invention also relates to DNA molecules encoding human somatomedin carrier protein-like polypeptides, recombinant DNA molecules, hosts, processes for producing carrier protein-like polypeptides, human somatomedin carrier protein-like polypeptides produced using those molecules, hosts and processes. The invention relates to DNA molecules and their expression in appropriate hosts. The recombinant DNA molecules contain DNA molecules that code for polypeptides which have a biological activity of the human carrier protein or a human carrier protein subunit capable of binding somatomedins. The DNA molecules, recombinant DNA molecules, hosts, and processes of this invention may be used in the production of polypeptides useful in a variety of therapeutic, diagnostic, and other useful applications.|
|Inventor(s):|| Spencer; Emerald M. (San Francisco, CA), Talkington-Verser; Carol (San Rafael, CA) |
|Assignee:|| Celtrix Pharmaceuticals, Inc. (Santa Clara, CA) |
|Filing Date:||May 12, 1995|
|Claims:||1. A method for measuring the level of unbound somatomedins in human fluids comprising: |
contacting an antibody with said human fluids which binds specifically to a carrier protein subunit which:
(a) has the N-terminal amino acid sequence, Gly-Ala-Ser-Ser-Ala-Gly-Leu-Gly-Pro-Val-Val-Arg-R-Glu-Pro-R-Asp-Ala-Arg-Al a-Leu-Ala, wherein R is a cysteine or half-cysteine;
(b) binds insulin-like growth factor 1 (IGF-I); and
(c) has a molecular weight of about 15,000 to 30,000 daltons as determined by sodium dodecyl sulfate gel electrophoresis under reducing conditions to separate somatomedins complexed with carrier protein subunits having the N-terminal amino acid sequence Gly-Ala-Ser-Ser-Ala-Gly-Leu-Gly-Pro-Val-Val-Arg-R-Glu-Pro-R-Asp-Ala-Arg-Al a-Leu-Ala- from the somatomedins not bound to said carrier protein subunits, and
measuring said somatomedins not bound to said carrier protein subunits.
2. The method of claim 1 wherein said somatomedins not bound to said carrier protein subunits are measured by RIA.